Oxidants in chronic kidney disease

  • Shah S
  • Baliga R
  • Rajapurkar M
 et al. 
  • 1


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Chronic kidney disease is a worldwide public health problem that affects approximately 10% of the US adult population and is associated with a high prevalence of cardiovascular disease and high economic cost. Chronic renal insufficiency, once established, tends to progress to end-stage kidney disease, suggesting some common mechanisms for ultimately causing scarring and further nephron loss. This review defines the term reactive oxygen metabolites (ROM), or oxidants, and presents the available experimental evidence in support of the role of oxidants in diabetic and nondiabetic glomerular disease and their role in tubulointerstitial damage that accompanies progression. It concludes by reviewing the limited human data that provide some proof of concept that the observations in experimental models may be relevant to human disease. Copyright © 2007 by the American Society of Nephrology.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • S.V. Shah

  • R. Baliga

  • M. Rajapurkar

  • V.A. Fonseca

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free